BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 16225713)

  • 1. Medical nebulizer performance: effects of cascade impactor temperature.
    Zhou Y; Ahuja A; Irvin CM; Kracko DA; McDonald JD; Cheng YS
    Respir Care; 2005 Aug; 50(8):1077-82. PubMed ID: 16225713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of nebulizer performance under various humidity conditions.
    Zhou Y; Ahuja A; Irvin CM; Kracko D; McDonald JD; Cheng YS
    J Aerosol Med; 2005; 18(3):283-93. PubMed ID: 16181003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro comparison of the circulaire and AeroTee to a traditional nebulizer T-piece with corrugated tubing.
    Piper SD
    Respir Care; 2000 Mar; 45(3):313-9. PubMed ID: 10771800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulations generated from ethanol-based proliposomes for delivery via medical nebulizers.
    Elhissi AM; Karnam KK; Danesh-Azari MR; Gill HS; Taylor KM
    J Pharm Pharmacol; 2006 Jul; 58(7):887-94. PubMed ID: 16805947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro delivery of budesonide from 30 jet nebulizer/compressor combinations using infant and child breathing patterns.
    Berg EB; Picard RJ
    Respir Care; 2009 Dec; 54(12):1671-8. PubMed ID: 19961633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of nebulized particle size distribution with Malvern laser diffraction analyzer versus Andersen cascade impactor and low-flow Marple personal cascade impactor.
    Kwong WT; Ho SL; Coates AL
    J Aerosol Med; 2000; 13(4):303-14. PubMed ID: 11262437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of flow pattern, device and formulation on particle size distribution of nebulized aerosol.
    Hu J; Zhang R; Beng H; Deng L; Ke Q; Tan W
    Int J Pharm; 2019 Apr; 560():35-46. PubMed ID: 30664994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aerodynamic characteristics of nebulized terbutaline sulphate using the Andersen Cascade Impactor compared to the Next Generation Impactor.
    Abdelrahim ME
    Pharm Dev Technol; 2011 Apr; 16(2):137-45. PubMed ID: 20100034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of methods to measure aerosols generated by a vibrating mesh nebulizer.
    Waldrep JC; Berlinski A; Dhand R
    J Aerosol Med; 2007; 20(3):310-9. PubMed ID: 17894537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of impactor operating flow rate on particle size distribution of four jet nebulizers.
    Zhou Y; Brasel TL; Kracko D; Cheng YS; Ahuja A; Norenberg JP; Kelly HW
    Pharm Dev Technol; 2007; 12(4):353-9. PubMed ID: 17763140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining a positive expiratory pressure device with a metered-dose inhaler reservoir system using chlorofluorocarbon albuterol and hydrofluoroalkane albuterol: effect on dose and particle size distributions.
    Rau JL; Torniainen M
    Respir Care; 2000 Mar; 45(3):320-6. PubMed ID: 10771801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of nebulizer droplet size distribution: a method based on impactor refrigeration.
    Berg E; Svensson JO; Asking L
    J Aerosol Med; 2007; 20(2):97-104. PubMed ID: 17536948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of a droplet evaporation model to aerodynamic size measurement of drug aerosols generated by a vibrating mesh nebulizer.
    Rao N; Kadrichu N; Ament B
    J Aerosol Med Pulm Drug Deliv; 2010 Oct; 23(5):295-302. PubMed ID: 20455771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication nebulizer performance. Effects of diluent volume, nebulizer flow, and nebulizer brand.
    Hess D; Fisher D; Williams P; Pooler S; Kacmarek RM
    Chest; 1996 Aug; 110(2):498-505. PubMed ID: 8697857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aerosol characteristics of admixture of budesonide inhalation suspension with a beta2-agonist, procaterol.
    Itazawa T; Adachi Y; Ito Y; Higuchi O; Mochizuki H; Shimojo N; Inoue T
    Allergol Int; 2013 Mar; 62(1):131-5. PubMed ID: 23348859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of tubing deposition, breathing pattern, and temperature on aerosol mass distribution measured by cascade impactor.
    Gurses BK; Smaldone GC
    J Aerosol Med; 2003; 16(4):387-94. PubMed ID: 14977429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Particle-size distribution of bitolterol mesylate solution delivered by four compressed-air nebulizer devices.
    Hunke WA; Yu AB
    Am J Hosp Pharm; 1987 Jun; 44(6):1392-6. PubMed ID: 3618619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of aerosol output from various nebulizer/compressor combinations.
    Reisner C; Katial RK; Bartelson BB; Buchmeir A; Rosenwasser LJ; Nelson HS
    Ann Allergy Asthma Immunol; 2001 May; 86(5):566-74. PubMed ID: 11379809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicochemical aspects and efficiency of albuterol nebulization: comparison of three aerosol types in an in vitro pediatric model.
    Sidler-Moix AL; Di Paolo ER; Dolci U; Berger-Gryllaki M; Cotting J; Pannatier A
    Respir Care; 2015 Jan; 60(1):38-46. PubMed ID: 25516995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Output and aerosol properties of 5 nebulizer/compressor systems with arformoterol inhalation solution.
    Bauer A; McGlynn P; Bovet LL; Mims PL; Curry LA; Hanrahan JP
    Respir Care; 2009 Oct; 54(10):1342-7. PubMed ID: 19796414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.